We would like to thank the McGill Regenerative Medicine (MRM) Network for their support of our project "Development of an eNOS endothelial colony forming cell reporter line" with the Fall 2021 Internal Funding Competition. We will be working with the Flow Cytometry Innovation Platform and Dr. Thomas Durcan in the Early Drug Discovery Unit (EDDU) to generate a genetically engineered stem cell line using the CRISPR-Cas9 system that will be used to study endothelial differentiation dynamics.